Comparison of chemotherapy plus bevacizumab vs. chemotherapy alone as third-line treatment or beyond for advanced non-small cell lung cancer: A propensity score-matched analysis

The addition of bevacizumab to chemotherapy has demonstrated efficacy as a first-line treatment for non-small cell lung cancer (NSCLC). Whether this combination is effective as a salvage treatment for patients with NSCLC remains unclear. The present retrospective study was designed to compare the ef...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncol Lett
Hauptverfasser: Hu, Binbin, Zhou, Xiaojuan, Liu, Yongmei, Li, Qian, Xiang, Mengmeng, Zou, Bingwen, Peng, Feng, Huang, Meijuan, Gong, Youling, Zhu, Jiang, Wang, Yongsheng, Ren, Li, Xu, Yong, Zhang, Yan, Li, Yanying, Yu, Min, Xue, Jianxin, Deng, Lei, Wang, Jin, Ding, Zhenyu, Lu, You
Format: Artigo
Sprache:Inglês
Veröffentlicht: D.A. Spandidos 2018
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5844063/
https://ncbi.nlm.nih.gov/pubmed/29556304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8064
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge